AACC calls for policies on AI in medical, healthcare fields

By LabPulse.com staff writers

July 30, 2021 -- The American Association for Clinical Chemistry (AACC) released a position statement urging federal agencies to implement policies for the healthcare community to use artificial intelligence (AI) and data analytics to transform patient care.

The AACC is also calling for the federal government to increase funding for the U.S. Centers for Disease Control and Prevention's ongoing effort to harmonize laboratory test results. It also said federal policy should prioritize payment reforms that promote secure, ethical, and reciprocal data sharing among health systems and providers.

The association also recommends that the clinical laboratory and healthcare communities collaborate to develop and promulgate standardized rules for data collection, sharing, and utilization.

AACC study details streamlined COVID testing protocol
A team of researchers has developed a new streamlined protocol for COVID-19 testing called SwabExpress. The protocol can increase the testing capacity...
AACC advises against Ct values for COVID patient care
The American Association for Clinical Chemistry (AACC) recently issued a public statement advising against using coronavirus test cycle threshold (Ct)...
AACC elects new board president, members
The American Association for Clinical Chemistry (AACC) has elected Shannon Haymond, PhD, as president-elect of its board of directors. The association...
AACC advises against lab testing for premature birth
Clinical lab tests that try to predict preterm birth shouldn't be used routinely due to a lack of evidence that the tests improve the outcomes of pregnant...
AACC releases guidance on kidney injury lab testing
The American Association for Clinical Chemistry (AACC) released guidance on lab testing for acute kidney injury patients that proposes new diagnostic...

Copyright © 2021 LabPulse.com

Last Updated np 9/1/2021 12:35:50 PM